Get the Stockscreener App
0.8735
102.57%
0.4423
After Hours:
.83
-0.0435
-4.98%
Werewolf Therapeutics Inc stock is traded at $0.8735, with a volume of 293.97M.
It is up +102.57% in the last 24 hours and up +140.63% over the past month.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
See More
Previous Close:
$0.4312
Open:
$0.98
24h Volume:
293.97M
Relative Volume:
51.57
Market Cap:
$42.45M
Revenue:
$1.14M
Net Income/Loss:
$-56.27M
P/E Ratio:
-0.7196
EPS:
-1.2139
Net Cash Flow:
$-51.94M
1W Performance:
+115.84%
1M Performance:
+140.63%
6M Performance:
+30.33%
1Y Performance:
-31.76%
1-Day Range:
$0.86
$1.05
1-Week Range:
$0.3922
$1.05
52-Week Range:
$0.27
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics Inc
Sector
Industry
Phone
617-952-0555
Address
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.8735 | 20.96M | 1.14M | -56.27M | -51.94M | -1.2139 |
VRTX
Vertex Pharmaceuticals Inc
|
548.05 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
834.04 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,039.78 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.13 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.46 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Downgrade | Wedbush | Outperform → Neutral |
| Apr-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-24-23 | Initiated | Wedbush | Outperform |
| Jun-06-23 | Resumed | Jefferies | Buy |
| Sep-10-21 | Initiated | BofA Securities | Buy |
| May-25-21 | Initiated | Evercore ISI | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | SVB Leerink | Outperform |
View All
Werewolf Therapeutics Inc Stock (HOWL) Latest News
Werewolf and Ambros Therapeutics announce merger - The Pharma Letter
Werewolf Therapeutics (NASDAQ:HOWL) Deal Changes Pipeline Focus - Kalkine Media
Werewolf Therapeutics Shares Surge Twofold After Ambros Merger, Investors Retain 6.8% Stake - TechStock²
Latham Watkins Advises on Oversubscribed Private Placement in Werewolf Ambros Merger Transaction - Latham & Watkins LLP
Werewolf Therapeutics, Inc. announced that it expects to receive $150 million in funding - marketscreener.com
Werewolf Therapeutics Strikes Reverse Merger With Ambros, Secures $150 Million for Rare Pain Drug - finance.biggo.com
Trending Stocks Today | Werewolf Therapeutics Shoots up 117.27% - Moomoo
Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News - Yahoo Finance
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Watertown biotech agrees to reverse merger with Vivek Ramaswamy-backed startup - The Business Journals
Gold Moves Higher; US Composite PMI Surges In August - Benzinga
Werewolf Therapeutics (HOWL) Stock Soars 127% on Ambros Merger and $150M Financing Deal - Blockonomi
Werewolf Therapeutics stock soars on Ambros merger deal and $150 million PIPE - Quiver Quantitative
Ambros Therapeutics to merge with Werewolf Therapeutics in all-stock deal - Dealroom
Why is Werewolf Therapeutics stock surging more than 100% today? - Investing.com
Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug - Fierce Biotech
Why Is Werewolf Therapeutics Stock Gaining Friday?Werewolf Therapeutics (NASDAQ:HOWL) - Benzinga
Israel Englander's HOWL Stock Soars on $500M DealWerewolf Therapeutics (NASDAQ:HOWL) - Benzinga
Werewolf Therapeutics to Merge and Rebrand as Ambros - TipRanks
Werewolf Therapeutics shares surge 120% after Ambros merger and $150 million financing - Yahoo Finance
HOWL Stock Whipsaws As One-Off Profit Meets Uncertain Future - StocksToTrade
Why Is Penny Stock Werewolf Therapeutics (HOWL) Up Today? - TipRanks
Werewolf (NASDAQ: HOWL) Ambros deal leaves holders with single-digit stake - Stock Titan
Werewolf Therapeutics to Merge With Ambros in Stock Deal; Raises $150 Million PIPE, Holders Locked Up - TradingView
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement - Investing News Network
Werewolf Therapeutics stock soars 120% on Ambros merger deal - Investing.com
HOWL Stock Jumps As One-Off Deal Reshapes Outlook - StocksToTrade
HOWL Stock Jumps As One-Time Deal Fuels Q2 Profit - timothysykes.com
Werewolf Therapeutics to merge with Ambros in $150m deal - Investing.com
Werewolf Therapeutics, Ambros Therapeutics Plan Merger With $150 Million Financing - citybiz
Werewolf Therapeutics to merge with Ambros in $150m deal By Investing.com - Investing.com India
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Werewolf Therapeutics and Ambros Therapeutics Announce - GlobeNewswire
Top Premarket Gainers - marketscreener.com
Great couple of days trading this!! 🐺 📊 📚 - Moomoo
Werewolf Therapeutics Shares Surge 89.94% After Hours on EMD Serono DealWerewolf Therapeutics (NASDAQ - Benzinga
Werewolf Therapeutics Sells Pre-Clinical Platforms to EMD for $33 Million - Minichart
Trending Stocks Today | Werewolf Therapeutics Soars 90.16% Post-Market - Moomoo
Werewolf Therapeutics Monetizes Platforms, Refocuses on Lead Programs - TipRanks
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Werewolf TherapeuticsOn August 14, Sells Inducer And Indukine Platforms To Emd Serono - TradingView
Werewolf Therapeutics Sells Preclinical Platforms to EMD Serono for $28M; Secures License for WTX-124/330 - TradingView
$Werewolf Therapeutics (HOWL.US)$ - Moomoo
Werewolf Therapeutics (HOWL) Q2 2026 Earnings: EPS Delivers 130.17% Surprise, Stock Moves HigherGuidance Update - vinanet.vn
Werewolf Therapeutics Inc (NASDAQ: HOWL) Share Price, HOWL Stock News, HOWL Share Price & Updates - Kalkine
Werewolf Therapeutics Company Profile & Introduction - moomoo.com
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
Werewolf Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Price to sales forward of Werewolf Therapeutics, Inc. – NASDAQ:HOWL - TradingView
Price to book forward of Werewolf Therapeutics, Inc. – NASDAQ:HOWL - TradingView
CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):